BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33094962)

  • 1. Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations.
    Isidori F; Bozzarelli I; Mastracci L; Malvi D; Lugaresi M; Molinari C; Söderström H; Räsänen J; D'Errico A; Fiocca R; Seri M; Krishnadath KK; Bonora E; Mattioli S
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00202. PubMed ID: 33094962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival.
    Visser E; Franken IA; Brosens LAA; de Leng WWJ; Strengman E; Offerhaus JA; Ruurda JP; van Hillegersberg R
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
    van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
    BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiregion sequencing and subclonal analysis reveal intratumoral heterogeneity in esophageal squamous cell carcinoma.
    Gao D; Zhang Z; Yang Q; Li B
    J Cancer Res Ther; 2021 Jul; 17(3):756-763. PubMed ID: 34269310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
    Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
    Davison JM; Yee M; Krill-Burger JM; Lyons-Weiler MA; Kelly LA; Sciulli CM; Nason KS; Luketich JD; Michalopoulos GK; LaFramboise WA
    PLoS One; 2014; 9(1):e79079. PubMed ID: 24454681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies.
    Hagen JA; DeMeester SR; Peters JH; Chandrasoma P; DeMeester TR
    Ann Surg; 2001 Oct; 234(4):520-30; discussion 530-1. PubMed ID: 11573045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.
    Malhotra U; Zaidi AH; Kosovec JE; Kasi PM; Komatsu Y; Rotoloni CL; Davison JM; R C; Irvin ; Hoppo T; Nason KS; Kelly LA; Gibson MK; Jobe BA
    PLoS One; 2013; 8(11):e78343. PubMed ID: 24223792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
    Thompson SK; Sullivan TR; Davies R; Ruszkiewicz AR
    Ann Surg Oncol; 2011 Jul; 18(7):2010-7. PubMed ID: 21267790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endoscopic therapy in early esophageal cancer.
    Malik S; Sharma G; Sanaka MR; Thota PN
    World J Gastroenterol; 2018 Sep; 24(35):3965-3973. PubMed ID: 30254401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
    Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
    J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing.
    Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ
    Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.